Background: Neurobehavioral distress significantly impacts people with dementia. Lighting interventions have shown positive effects in this population, yet most did not accommodate natural daylight. This study developed an innovative, bright light system, the smart ambient bright light (SABL), that provides auto-controlled, consistent indoor lighting and accommodates natural daylight. This study evaluated the effect of the SABL on neurobehavioral symptoms and affect in nursing home (NH) residents with dementia.
Method: This crossover, cluster randomized control trial recruited residents with dementia and agitation from two NHs in Pennsylvania. The study had five phases: baseline, intervention, post-intervention/washout, control, and post-control/washout. The intervention and control phases were four weeks each, and the intervention sequence was randomly assigned. The SABL was installed in residents' bedrooms and common areas. Neurobehavioral symptoms and affect were measured at baseline and biweekly. The Neuropsychic Inventory (NPI) was calculated as a total score and four subscales: psychosis hyperactivity, mood, and frontal. Repeated measures analysis of variance were conducted.
Result: 27 NH residents completed the study. Participants averaged 87.4 years and were primarily female (74.1%). After controlling for age, dementia stage, and gender, participants' scores on NPI total (p = 0.007), hyperactivity (p = 0.04), mood (p = 0.03), and psychosis (p = 0.02) were statistically significantly lower during the intervention period as compared to the control period. Participants' affect did not show a significant difference. No intervention-related adverse effects were reported. Moreover, NH staff reported favorably that they would like the SABL to be used in their facility with an average rating of 4.1 on a 1-5 rating scale.
Conclusion: Overall, results suggest that the SABL is well-accepted and has a positive impact on most neurobehavioral symptoms in NH residents with dementia. Future studies may replicate the study in a larger, more diverse population, examine the intervention fidelity, and establish implementation strategies in NHs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.087626 | DOI Listing |
Alzheimers Dement
December 2024
Neurobehavioral Systems, Inc, Berkeley, CA, USA.
Background: Paper-and-pencil neuropsychological tests have traditionally been considered the "gold standard" for clinical testing in AD/ADRD, but they have significant limitations: They are time-consuming, costly to administer, vulnerable to examiner bias and error, and unavailable to some patients due to location, transportation challenges, and cost. Manual tests also fail to comprehensively analyze many aspects of test performance. Computerized neuropsychological test batteries have been developed to address these shortcomings.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
IDEAS Institute, Cleveland Heights, OH, USA.
Background: Neurobehavioral distress significantly impacts people with dementia. Lighting interventions have shown positive effects in this population, yet most did not accommodate natural daylight. This study developed an innovative, bright light system, the smart ambient bright light (SABL), that provides auto-controlled, consistent indoor lighting and accommodates natural daylight.
View Article and Find Full Text PDFNicotine Tob Res
January 2025
Professor and Director of Center for Neurobehavioral Research on Addiction, Louis A. Faillace, M.D., Department of Psychiatry and Behavioral Sciences, UTHealth, McGovern Medical School, 1941 East Road, BBSB, Houston, TX.
Introduction: Understanding predictors of smoking cessation medication efficacy facilitates the ability to enhance treatment effectiveness. In our pilot trial, exenatide, a glucagon-like peptide-1 receptor agonist, adjunct to nicotine patch improved smoking abstinence compared to nicotine patch alone. This secondary analysis explores potential baseline characteristics associated with differential treatment response to exenatide.
View Article and Find Full Text PDFNpj Ment Health Res
January 2025
Department of Psychiatry, University Hospital Infanta Leonor, 28031, Madrid, Spain.
Attention-deficit/hyperactivity disorder (ADHD) presents with symptoms like impulsiveness, inattention, and hyperactivity, often affecting children's academic and social functioning. Non-pharmacological interventions, such as digital cognitive therapy, are emerging as complementary treatments for ADHD. The randomized controlled trial explored the impact of an AI-driven digital cognitive program on impulsiveness, inattentiveness, and neurophysiological markers in 41 children aged 8-12 with ADHD.
View Article and Find Full Text PDFTrimethyltin chloride (TMT), an organotin compound with potent neurotoxicity, is widely used as a heat stabilizer for plastics. However, the precise pathogenic mechanism of TMT remains incompletely elucidated, and there persists a dearth of sensitive detection methodologies for early diagnosis of TMT. In this study, Sprague-Dawley rats were treated with 10 mg/kg TMT to simulate acute exposure in humans.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!